Log In

Healthcare & Pharmaceuticals Blog

Recent Posts

  • Blog: Biologics BlogPart I: Stakeholder Comments on FDA’s Interchangeability Guidance for BiosimilarsPosted on May 22, 2017 by
    The comment period for FDA’s draft guidance Considerations in Demonstrating Interchangeability With a Reference Product closed on Friday, May 19, 2017.  Innovators, biosimilar makers, patients, healthcare providers and other stakeholders have weighed in on the long-awaited guidance.  Interchangeable biosimilars, unlike other biosimilars, may be substituted for the innovator product without the intervention of the healthcare [...]
    READ FULL ARTICLE
  • Blog: Biotech Business LawyerGenetically Modified Rice vs. ChinaPosted on March 11, 2013 by biotechbusinesslawyer
    A March 7, 2013 piece on Morning Edition, the morning news program from National Public Radio, raised a lot of questions. “In A Grain Of Golden Rice, A World Of Controversy Over GMO Foods” told the story of golden rice, … Continue reading →
    READ FULL ARTICLE

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | DISCLAIMER |  © World Services Group, 2017